Global Epilepsy Drug Market (2022-2027): Rising Drug Approvals of Anticonvulsant Drugs from Regulatory Bodies Presents Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Epilepsy Drug Market (2022-2027) by Product Type, Distribution Channel, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis." report has been added to ResearchAndMarkets.com's offering.

The Global Epilepsy Drug Market is estimated to be USD 4.22 Bn in 2022 and is expected to reach USD 5.9 Bn by 2027, growing at a CAGR of 6.94%.

Market Dynamics

Drivers

• Growing Prevalence of Epilepsy
• Rising Incidence of Neurological Disorders, Birth-Related Injuries, and Traffic Injuries
• Rising Investment and Support from the Government

Restraints

• Scarcity of Treatment for Epilepsy in Low-Income Countries

Opportunities

• Rising Drug Approvals of Anticonvulsant Drugs from Regulatory Bodies
• Penetration of Collaboration and Product Launch Activities

Challenges

• Side Effects Associated with The Drugs

Market Segmentations

The Global Epilepsy Drug Market is segmented based on Product Type, Distribution Channel, and Geography.

• By Product Type, the market is classified into First-generation Drugs, Second-generation Drugs, and Third Generation Drugs.
• By Distribution Channel, the market is classified into Hospital Pharmacy and Pharmacy Stores.
• By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Epilepsy Drug Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Epilepsy Drug Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Epilepsy Drug Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
• The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report also contains the competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

• A complete analysis of the market, including parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics

5 Market Analysis

6 Global Epilepsy Drug Market, By Product Type

7 Global Epilepsy Drug Market, By Distribution Channel

8 Americas' Epilepsy Drug Market

9 Europe's Epilepsy Drug Market

10 Middle East and Africa's Epilepsy Drug Market

11 APAC's Epilepsy Drug Market

12 Competitive Landscape

13 Company Profiles

14 Appendix

Companies Mentioned

• Abbott Laboratories
• Eisai Corp. Ltd.
• GSK PLC
• Johnson & Johnson
• Novartis International Ag
• Pfizer Inc.
• Sanofi s.a.
• Sunovion Pharmaceuticals, Inc.
• Teva Pharmaceutical Industries Ltd.
• UCB s.a.

For more information about this report visit https://www.researchandmarkets.com/r/dz0ysd

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900